
Global Clinical Operations Leader with 20+ years’ experience delivering Phase I–IV clinical trials across complex, multi-country programmes. Proven expertise in strategic vendor oversight, outsourced clinical delivery models (FSP & CRO), and risk-based trial execution.
Track record of driving performance across global vendor ecosystems through structured governance frameworks, KPI tracking, and proactive risk mitigation, ensuring delivery against timelines, budget, and regulatory expectations.
Demonstrated impact in improving operational efficiency and data quality, including >98% data accuracy and 20% reduction in query resolution timelines through optimisation of systems such as Medidata Rave and Veeva Vault.
Extensive experience across oncology, cardiovascular, and rare disease programmes, with strong capability in investigator engagement, site intelligence, and enrolment optimisation.
Global Phase II/III Oncology Programmes | Multi-Country Delivery
Global Oncology Studies | Full Vendor Oversight
Pfizer | Ipsen | Johnson & Johnson | INC Research | 2007 – 2013